Registration of Avacta’s AffiDX® SARS-CoV-2 Antigen Lateral Flow Test in EU
Avacta Group PLC (AVCT.L) Registration of AffiDX Lateral Flow Test in EU
Avacta Group PLC (AVCT.L) Response to speculation
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, notes speculation regarding the ongoing CE mark submission for
Avacta Group PLC (AVCT.L) Posting of Annual Report and Notice of AGM
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that its Annual Report and
Avacta Group PLC (AVCT.L) AffiDX SARS-CoV-2 Antigen Lateral Flow Test Update
Submission of Declaration of Conformity for CE mark for Avacta’s rapid antigen test
Avacta Group PLC (AVCT.L) Final Results
Preliminary Results for the year ending 31 December 2020
Share Talk Bulletin Board Heroes, Tuesday 20th April 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Avacta Group PLC (AVCT.L) Clinical validation of AffiDX ® SARS-CoV-2 Antigen Lateral Flow Test
98.0% clinical sensitivity for samples with PCR Ct values [1] up to 31
Share Talk Bulletin Board Heroes, Thursday 1st April 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Avacta Group PLC (AVCT.L) Directorate Change
Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces that the Dr Mike Owen has stepped down
Share Talk Bulletin Board Heroes, Wednesday 10th March 2021
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Avacta Group PLC (AVCT.L) Rapid Antigen Test Detects SARS-CoV-2 Variants
Avacta’s AffiDX® SARS-CoV-2 lateral flow test detects both B117 ‘Kent’ and D614G variants of the virus
